The Current Ratio as of November 2024 (TTM) for Vor Biopharma Inc. (VOR) is 4.69

According to Vor Biopharma Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.69. This represents a change of -34.70% compared to the average of 7.18 of the last 4 quarters.

Vor Biopharma Inc. (VOR) Historical Current Ratio (quarterly & annually)

How has VOR Current Ratio performed in the past?

The mean historical Current Ratio of Vor Biopharma Inc. over the last ten years is 9.43. The current 4.69 Current Ratio has changed 4.87% with respect to the historical average. Over the past ten years (40 quarters), VOR's Current Ratio was at its highest in in the March 2021 quarter at 30.85. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Vor Biopharma Inc. (VOR) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Vor Biopharma Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vor Biopharma Inc. (VOR) Average Current Ratio

How has VOR Current Ratio performed in the past?

The current Current Ratio of Vor Biopharma Inc. (VOR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Vor Biopharma Inc. (VOR) Current Ratio vs. Peers

How is VOR’s Current Ratio compared to its peers?

Vor Biopharma Inc.’s Current Ratio is less than Gracell Biotechnologies Inc. (7.73), less than Theseus Pharmaceuticals, Inc. (29.93), less than Monte Rosa Therapeutics, Inc. (6.03), less than Design Therapeutics, Inc. (34.61), less than Erasca, Inc. (11.00), less than Edgewise Therapeutics, Inc. (26.35), less than Talaris Therapeutics, Inc. (18.64), less than Adicet Bio, Inc. (10.64), less than Cullinan Oncology, Inc. (24.46), less than Nuvalent, Inc. (23.07), less than Ventyx Biosciences, Inc. (23.52), greater than Arcellx, Inc. (4.29), greater than Kiniksa Pharmaceuticals, Ltd. (3.24), greater than Bolt Biotherapeutics, Inc. (3.16), less than Day One Biopharmaceuticals, Inc. (14.62), greater than Lyra Therapeutics, Inc. (3.64), less than Autolus Therapeutics plc (13.69), less than Foghorn Therapeutics Inc. (4.77), less than Shattuck Labs, Inc. (7.96), less than Kymera Therapeutics, Inc. (8.55), less than Nurix Therapeutics, Inc. (5.28),

Build a custom stock screener for Vor Biopharma Inc. (VOR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vor Biopharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vor Biopharma Inc. (VOR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vor Biopharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.